# Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)

> **NCT00931606** · PHASE2 · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 30 (actual)

## Conditions studied

- Chemotherapy Induced Anemia

## Interventions

- **BIOLOGICAL:** Sotatercept
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00931606
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06-01
- **Primary completion:** 2010-11-18
- **Final completion:** 2010-11-18
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** administrative reasons (slow patient enrollment)
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00931606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00931606, "Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00931606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*